Kinnate Biopharma OverviewKinnate Biopharma Net Income
Profitability analysis for KNTE.
Quarterly Net Income
-$17.06M
↑ 43.04% YoY
As of Dec 2023
Annual Net Income (TTM)
-$110.94M
↑ 2.28% YoY
Trailing 12 months ending Dec 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...